Page 22 - 83_02
P. 22
Ana Hernando Holgado, Luis García de Guadiana, Ana Fernández-Carballido, M. Dolores Albaladejo Otón
Diagnostic value and prognostic evaluation of 35:1859–67
Presepsin for sepsis in an emergency department. Crit
Care. 2013; 17: R244. 56. Suberviola B, Castellanos-Ortega A, Ruiz Ruiz A,
Lopez-Hoyos M, Santibañez M. Hospital mortality
44. Miyata M, Sato N, Takahashi. The utility of the prognostication in sepsis using the new biomarkers
soluble CD14 subtype for diagnosis of sepsis, the suPAR and proADM in a single determination on ICU
examination of the simple diagnostic kit. J Iwate med admission. Intensive Care Med. 2013; 39: 1945–52.
Assoc. 2007;59:325–31.
57. Cavallazzi R, El-Kersh K, Abu-Atherah E, Singh S,
45. García de Guadiana L, Esteban P, Viqueira M, Loke YK, Wiemken T, et al. Midregional
Jiménez R, Hernando A,Ortín A et al. Diagnostic proadrenomedullin for prognosis in community-
accuracy of presepsin (soluble CD14 subtype) for acquired pneumonia: A systematic review. Respir.
prediction of bacteremia in patients with systemic Med. 2014: 108: 1569–80.
inflammatory response syndrome in the Emergency
Department. Clin Biochem. 2014; 47: 505–8. 58. España PP, Capelastegui A, Mar C, Bilbao A,
Quintana JM, Diez R, et al. Performance of pro-
46. Kweon OJ, Choi JH, Park SK, Park AJ. Usefulness of adrenomedullin for identifying adverse outcomes in
presepsin (sCD14 subtype) measurements as a new community-acquired pneumonia. J. Infect. 2015; 70:
marker for the diagnosis and prediction of disease 457–66
severity of sepsis in the Korean population. J. Crit.
Care. 2014; 29:965–70. 59. Andaluz-Ojeda D, Cicuéndez R, Calvo D, Largo E,
Nogales L, Muñoz MF, et al. Sustained value of
47. Sato M, Takahashi G, Shibata S, Onodera M, Suzuki proadrenomedullin as mortality predictor in severe
Y, Inoue Y, et al. Clinical Performance of a New sepsis. J. Infect. 2015; 71: 136–9.
Soluble CD14-Subtype Immunochromatographic Test
for Whole Blood Compared with Chemiluminescent 60. Valenzuela Sanchez F, Valenzuela Mendez B,
Enzyme Immunoassay: Use of Quantitative Soluble Bohollo de Austria R, Rodríguez Gutierrez J, Jaen
CD14-Subtype Immunochromatographic Tests for the Franco M, González García M, et al. Diagnostic and
Diagnosis of Sepsis. PLoS One. 2015; 10: e0143971. prognostic usefulness of Mid-Regional Pro-
Aadrenomedullin levels in patients with severe sepsis.
48. Kitamura K, Kangawa K, Kawamoto K, Ichiki Y, Intensive Care Med. Exp. 2015: 3: A306.
Nakamura S, et al. Adrenomedullin: a novel
hypotensive peptide isolated from human 61. Bouchon A, Facchetti F, Weigand MA, Colonna M.
pheochromocytoma. Biochem Biophys Res Commun. TREM-1 amplifies inflammation and is a crucial
1993;192:553–60. mediator of septic shock. Nature. 2001; 410: 1103–7.
49. Ishimitsu T, Kojima M, Kangawa K, Hino J, 62. Gibot S, Massin F. Soluble form of the triggering
Matsuoka H, et al. Genomic structure of human receptor expressed on myeloid cells 1: an anti-
adrenomedullin gene. Biochem Biophys Res inflammatory mediator? Intensive Care Med. 2006:
Commun. 1994;203:631–9. 32: 185–7.
50. Hinson JP, Kapa S, Smith DM. Adrenomedullin, a 63. Jiyong J, Tiancha H, Wei C, Huahao S. Diagnostic
multifunctional regulatory peptide. Endocr Rev. value of the soluble triggering receptor expressed on
2000;21:138–67. myeloid cells-1 in bacterial infection: a meta-analysis.
Intensive Care Med. 2009;35(4):587–95.
51. Cases A, Mora-Macía J. Adrenomedullin: a new
vasoactive peptide. Nefrologia. 2001;21:16–25. 64. Latour-Pérez J, Alcalá -López A, García-García MA,
Sánchez-Hernández JF, Abad-Terrado C, Viedma-
52. Ornan DA, Chaudry IH, Wang P. Saturation of Contreras JA, et al. Valor pronóstico de los niveles
adrenomedullin receptors plays an important role in plasmáticos de sTREM-1 en pacientes con sepsis: Un
reducing pulmonary clearance of adrenomedullin estudio de cohortes. Med Intensiva. 2010;34(4):231–
during the late stage of sepsis. Biochim Biophys Acta. 6.
2002;1586:299–306.
65. Gibot S, Cravoisy A, Kolopp-Sarda M-N, Béné M-C,
53. Lewis LK, Smith MW, Yandle TG, Richards AM, Faure G, Bollaert P-E, et al. Time-course of sTREM
Nicholls MG. Adrenomedullin(1-52) measured in (soluble triggering receptor expressed on myeloid
human plasma by radioimmunoassay: plasma cells)-1, procalcitonin, and C-reactive protein plasma
concentration, adsorption, and storage. Clin Chem. concentrations during sepsis. Crit. Care Med. 2005;
1998;44:571–7. 33:792–6.
54. Christ-Crain M, Morgenthaler NG, Struck J, Harbarth 66. Phua J, Koay ESC, Zhang D, Lee KH. How well do
S, Bergmann A, Müller B. Mid-regional pro- serum sTREM-1 measurements prognosticate in septic
adrenomedullin as a prognostic marker in sepsis: an shock? Anaesth. Intensive Care. 2008; 36:654–8.
observational study. Crit Care. 2005;9(6):816–24.
67. Valor diagnóstico de la inmunoglobulina sTREM-1 en
55. Guignant C, Voirin N, Venet F, Poitevin F, Malcus C, la neumonía de los pacientes ventilados
Bohé J, et al. Assessment of pro-vasopressin and pro- mecánicamente. Med Intensiva. 2004; 28: 386–9.
adrenomedullin as predictors of 28-day mortality in
septic shock patients. Intensive Care Med. 2009: 68. Thunø M, Macho B, Eugen-Olsen J. suPAR: the
molecular crystal ball. Dis Markers. 2009; 27: 157–72.
186 @Real Academia Nacional de Farmacia. Spain
